Skip to main content
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc.

Track CRVS — free
$14.39 -0.26 (-1.77%) At close · Sep 4
Market Cap
$1.21B
Shares
84.12M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

CRVS Latest Reported Short Interest

FINRA reported 19,127,098 CRVS shares sold short as of the August 14, 2026 settlement date, an increase of 816,842 shares. Days to cover was 22.53 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

CRVS Short Interest Forecast

Equibles' model estimates 19,488,467 shares sold short for the August 31, 2026 settlement, +1.9% versus the latest reported position, with a likely range of 18,185,437 to 20,714,268 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 31 Low confidence 58% chance it falls
19,488,467 +1.9% vs reported
Likely range 18,185,437 to 20,714,268 The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
81/100
Short interest 22.7% of shares — P99 Days to cover 22.5 — P97 Price vs VWAP +4.2% — P69 Short-volume trend +2.4% — P60 Short interest change +4.5% — P67 Worst FTD 0.02% of shares — P61

Peer-relative percentile rank across all listed securities reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-09-15 Scheduled
FINRA publishes Sep 24
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 19,127,098 18,310,256 +816,842 22.53
2026-07-31 18,310,256 18,061,919 +248,337 22.50
2026-07-15 18,061,919 18,819,891 -757,972 12.59
2026-06-30 18,819,891 17,882,834 +937,057 12.38
2026-06-15 17,882,834 17,324,311 +558,523 14.37
2026-05-29 17,324,311 18,910,283 -1,585,972 8.45
2026-05-15 18,910,283 18,385,941 +524,342 11.98
2026-04-30 18,385,941 16,928,111 +1,457,830 11.54
2026-04-15 16,928,111 16,951,894 -23,783 21.77
2026-03-31 16,951,894 16,054,916 +896,978 11.09
2026-03-13 16,054,916 16,009,857 +45,059 14.71
2026-02-27 16,009,857 14,883,150 +1,126,707 13.29
2026-02-13 14,883,150 14,678,521 +204,629 9.81
2026-01-30 14,678,521 11,486,255 +3,192,266 1.09
2026-01-15 11,486,255 11,816,663 -330,408 7.54
2025-12-31 11,816,663 9,383,518 +2,433,145 6.47
2025-12-15 9,383,518 9,812,924 -429,406 6.71
2025-11-28 9,812,924 9,902,822 -89,898 12.97
2025-11-14 9,902,822 9,028,415 +874,407 8.72
2025-10-31 9,028,415 8,833,502 +194,913 8.88
2025-10-15 8,833,502 10,096,570 -1,263,068 7.85
2025-09-30 10,096,570 9,670,508 +426,062 12.64
2025-09-15 9,670,508 9,593,924 +76,584 15.37

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1626971 CUSIP 221015100 13F (30d) 139 filings 139 filers Visit website Investor relations